Glucose Intolerance
140
9
12
91
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
14 trials with published results (10%)
Research Maturity
91 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.0%
7 terminated out of 140 trials
92.9%
+6.4% vs benchmark
14%
19 trials in Phase 3/4
15%
14 of 91 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 91 completed trials
Clinical Trials (140)
Effect of a Low-carb Dietary Intervention in Obese Patients: a Pilot Trial
Time to Move in Pregnancy Hyperglycemia
Effects of Tagatose on Glycemic Response and Gastrointestinal Microbiota in Healthy Adults
Physical Inactivity Impacts on Blood Vessel Health and Glucose Levels in an Aging Population
Effects of Acute Sleep Deprivation on Health
Impact of Nocturnal Hypoxemia on Glucose in High Altitude Sleep Disordered Breathing
Inositol Supplementation to Treat PCOS (INSUPP-PCOS)
Effects of Dapagliflozin on Inflammatory Factorslevel and Prognosis in Type 2 Diabetes With Acute Myocardial Infarction
Impact of Sorghum Rice on Beta-Cell Function and Insulin Resistance in Prediabetes
A Biological Atlas of Severe Obesity (Biological Tissue Collection)
Abnormal Post-partum Glucose Metabolism After Gestational Diabetes Diagnosed Before or After 24 Weeks of Gestation
Influence of Nocturnal Light Exposure on the Impairment of Glucose Tolerance Induced by Chronic Sleep Restriction
Sucralose and Glucose Metabolism in Young Healthy Adults
Assessing Metabolic and Sleep Consequences of Overnight Home Parenteral Nutrition
Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance
Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)
Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform
Extracellular Vesicle Cargo in Obesity and Type 2 Diabetes
Daily Vinegar Ingestion and 24-Hour Blood Glucose Control
Rare and Atypical Diabetes Network